Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/10/2024 | CALL | $145.00 | 980 | +908 | +1,261.11% |
| 05/17/2024 | CALL | $145.00 | 1,589 | +623 | +64.49% |
| 04/19/2024 | CALL | $150.00 | 4,173 | +481 | +13.03% |
| 05/17/2024 | CALL | $150.00 | 2,366 | +398 | +20.22% |
| 05/03/2024 | CALL | $162.50 | 381 | +377 | +9,425.00% |
| 04/19/2024 | PUT | $132.00 | 369 | +364 | +7,280.00% |
| 04/19/2024 | CALL | $147.00 | 1,633 | -235 | -12.58% |
| 04/19/2024 | PUT | $155.00 | 6,793 | -291 | -4.11% |
| 05/17/2024 | PUT | $160.00 | 572 | -302 | -34.55% |
| 04/19/2024 | CALL | $148.00 | 806 | -327 | -28.86% |
| 04/19/2024 | CALL | $146.00 | 1,007 | -342 | -25.35% |
| 04/19/2024 | PUT | $150.00 | 1,867 | -420 | -18.36% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.55% | 79.47M | 12.56B |
| Vanguard 500 Index Fund | 1.94% | 60.44M | 9.55B |
| Fidelity 500 Index Fund | 0.92% | 28.66M | 4.53B |
| SPDR S&P 500 ETF Trust | 0.91% | 28.31M | 4.47B |
| iShares Core S&P 500 ETF | 0.75% | 23.33M | 3.69B |
| Vanguard Index-Value Index Fund | 0.72% | 22.6M | 3.57B |
| Select Sector SPDR Fund-Health Care | 0.68% | 21.24M | 3.36B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.59% | 18.32M | 2.9B |
| Vanguard Specialized-Dividend Appreciation Index Fund | 0.53% | 16.62M | 2.63B |
| Washington Mutual Investors Fund | 0.40% | 12.37M | 1.96B |
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
04/19 09:15 am
Zacks Investment Research
Read moreThe Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron
04/19 06:00 am
Zacks Investment Research
Read moreTop Stock Reports for NVIDIA, Alphabet & Johnson & Johnson
04/18 12:22 pm
Zacks Investment Research
Read moreJohnson & Johnson Analysts Cut Their Forecasts After Q1 Results
04/17 01:51 pm
Benzinga
Read moreJNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
04/17 10:00 am
Zacks Investment Research
Read moreCompany News for Apr 17, 2024
04/17 09:17 am
Zacks Investment Research
Read moreVisa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
04/17 08:21 am
Benzinga
Read moreWhy Johnson & Johnson Stock Got Tossed by the Market Today
04/16 05:45 pm
The Motley Fool
Read moreJohnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
04/16 01:30 pm
The Motley Fool
Read moreStocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
04/16 01:28 pm
Benzinga
Read moreBuilding Permits Come in Lower Than Expected
04/16 11:02 am
Zacks Investment Research
Read moreJ&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
04/16 10:53 am
Zacks Investment Research
Read moreHousing Numbers Shrink as Q1 Earnings Heat Up: BAC, JNJ, UNH
04/16 10:26 am
Zacks Investment Research
Read moreJohnson & Johnson (JNJ) Reports Q1 Earnings: What Key Metrics Have to Say
04/16 09:30 am
Zacks Investment Research
Read moreJohnson & Johnson (JNJ) Q1 Earnings Top Estimates
04/16 07:30 am
Zacks Investment Research
Read moreWall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
04/16 07:24 am
Benzinga
Read moreShould You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
04/16 06:20 am
Zacks Investment Research
Read moreJohnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
04/16 02:15 am
Benzinga
Read moreBank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
04/16 02:10 am
Benzinga
Read moreFear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
04/16 02:09 am
Benzinga
Read moreMedical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA
04/15 02:42 pm
Benzinga
Read moreA Closer Look at 9 Analyst Recommendations For Johnson & Johnson
04/15 11:01 am
Benzinga
Read moreShould You Buy Johnson & Johnson (JNJ) Ahead of Earnings?
04/15 10:06 am
Zacks Investment Research
Read more5 U.S. Bigwigs Likely to Gain on Q1 Earnings Beat This Week
04/15 08:19 am
Zacks Investment Research
Read moreWall Street Breakfast: The Week Ahead
04/14 07:51 am
Seeking Alpha
Read moreJohnson & Johnson (JNJ) Stock Moves -0.85%: What You Should Know
04/12 05:45 pm
Zacks Investment Research
Read more3 Quarterly Releases to Watch Next Week
04/12 03:00 pm
Zacks Investment Research
Read moreRallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
04/12 10:23 am
Zacks Investment Research
Read morePharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
04/12 09:22 am
Zacks Investment Research
Read moreJ&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
04/12 09:09 am
Zacks Investment Research
Read more5 Dividend Kings That Yield More Than Vanguard's Top Value ETF
04/12 08:00 am
The Motley Fool
Read more5 Things To Know In Investing This Week - The Shockwave Takeover Issue
04/11 10:02 am
Benzinga
Read moreUnlocking Q1 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics
04/11 09:15 am
Zacks Investment Research
Read moreInvestors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
04/11 09:00 am
Zacks Investment Research
Read moreWant Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
04/10 08:50 am
Zacks Investment Research
Read moreDoes Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
04/10 04:57 am
The Motley Fool
Read moreJohnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04/09 10:00 am
Zacks Investment Research
Read moreHow's AT&T Handling Things?
04/09 09:51 am
The Motley Fool
Read more3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
04/09 04:21 am
The Motley Fool
Read moreHere's Why Johnson & Johnson (JNJ) Fell More Than Broader Market
04/08 05:50 pm
Zacks Investment Research
Read moreJohnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
04/08 02:19 pm
Benzinga
Read moreJohnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says
04/08 01:27 pm
Benzinga
Read moreBristol Myers (BMY) Gets FDA Nod for Label Expansion of Abecma
04/08 01:27 pm
Zacks Investment Research
Read moreFDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
04/08 09:40 am
Zacks Investment Research
Read moreJ&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
04/08 09:18 am
Zacks Investment Research
Read more2 Dividend Stocks to Buy and Hold Forever
04/08 03:46 am
The Motley Fool
Read more5 Relatively Secure And Cheap Dividend Stocks To Invest In - April 2024
04/06 09:30 am
Seeking Alpha
Read moreCan a New CEO Fix Boeing?
04/06 08:15 am
The Motley Fool
Read more